We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$884M
AUM Growth
+$6.79M
Cap. Flow
-$8.89M
Cap. Flow %
-1.01%
Top 10 Hldgs %
21.23%
Holding
269
New
8
Increased
62
Reduced
115
Closed
6

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.95M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
TEL icon
TE Connectivity
TEL
+$2.39M
4
V icon
Visa
V
+$1.47M
5
AMT icon
American Tower
AMT
+$1M

Top Sells

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$6.62M
2
ORCL icon
Oracle
ORCL
+$5.59M
3
MON
Monsanto Co
MON
+$2.64M
4
XOM icon
ExxonMobil
XOM
+$1.85M
5
GE icon
GE Aerospace
GE
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 16.41%
2 Technology 15.55%
3 Industrials 11.64%
4 Consumer Staples 8.49%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
26
DELISTED
Celgene Corp
CELG
$9.65M 1.09%
121,475
-10,479
-8% -$870K
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.59T
$9.31M 1.05%
166,900
+17,120
+11% +$925K
SYK icon
28
Stryker
SYK
$129B
$8.95M 1.01%
52,994
-461
-0.9% -$77.5K
VZ icon
29
Verizon
VZ
$195B
$8.83M 1%
175,503
-1,325
-0.7% -$64.1K
MIDD icon
30
Middleby
MIDD
$6.27B
$8.8M 1%
84,246
-240
-0.3% -$27.2K
GIS icon
31
General Mills
GIS
$19.3B
$8.72M 0.99%
197,066
-200
-0.1% -$8.75K
MKC icon
32
McCormick & Company Non-Voting
MKC
$14B
$8.63M 0.98%
148,720
+3,758
+3% +$197K
ROP icon
33
Roper Technologies
ROP
$38.8B
$8.53M 0.97%
30,931
+3,451
+13% +$952K
PEP icon
34
PepsiCo
PEP
$190B
$8.37M 0.95%
76,845
-1,116
-1% -$115K
DLTR icon
35
Dollar Tree
DLTR
$25.1B
$8.14M 0.92%
95,821
+497
+0.5% +$45.8K
ABBV icon
36
AbbVie
ABBV
$431B
$8.06M 0.91%
86,947
-752
-0.9% -$73.4K
NEE icon
37
NextEra Energy
NEE
$182B
$7.97M 0.9%
190,948
+11,664
+7% +$471K
GILD icon
38
Gilead Sciences
GILD
$168B
$7.92M 0.9%
111,762
-2,276
-2% -$161K
PX
39
DELISTED
Praxair Inc
PX
$7.9M 0.89%
49,930
-25
-0.1% -$3.86K
AFL icon
40
Aflac
AFL
$63.7B
$7.58M 0.86%
176,104
– –
CVS icon
41
CVS Health
CVS
$133B
$7.45M 0.84%
115,747
+4,607
+4% +$304K
QQQ icon
42
Invesco QQQ Trust
QQQ
$485B
$7.15M 0.81%
41,652
+727
+2% +$122K
MMM icon
43
3M
MMM
$93.6B
$6.86M 0.78%
41,679
-3,625
-8% -$619K
MRK icon
44
Merck
MRK
$316B
$6.52M 0.74%
112,524
+1,765
+2% +$99.6K
ABT icon
45
Abbott
ABT
$182B
$6.46M 0.73%
105,833
+1,575
+2% +$95.5K
AL
46
DELISTED
Air Lease Corp
AL
$6.4M 0.72%
152,480
-3,669
-2% -$159K
WAB icon
47
Wabtec
WAB
$50.5B
$6.3M 0.71%
63,867
-200
-0.3% -$18.6K
MCD icon
48
McDonald's
MCD
$191B
$6.02M 0.68%
38,400
-375
-1% -$60.8K
SRCL
49
DELISTED
Stericycle Inc
SRCL
$5.92M 0.67%
90,593
-4,460
-5% -$277K
GLNG icon
50
Golar LNG
GLNG
$5.03B
$5.89M 0.67%
199,790
-3,051
-2% -$92.7K
1
2
3 4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Family Office held 269 positions worth $884M, up 0.77% from $877M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q2 2018 filing shows 8 new, 62 increased, 115 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M. The largest sale was Parker-Hannifin, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q2 2018 buy was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M.
  • Boston Family Office added most to Amazon in Q2 2018, an estimated $2.94M increase.
  • Boston Family Office's biggest Q2 2018 reduction was Parker-Hannifin, cutting an estimated $6.62M.
  • Boston Family Office fully exited Monsanto Co in Q2 2018, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $884M portfolio in Q2 2018.
  • Boston Family Office opened 8 new positions and closed 6 in Q2 2018.
  • Boston Family Office's portfolio value rose 0.77% quarter-over-quarter to $884M.

Based on Boston Family Office's 13F filing for Q2 2018, filed 26 Jul 2018.